Skip to content

Tag: Treatment limitations

Explore our medication guides and pharmacology articles within this category.

Why is Zolgensma not a cure? Understanding its limitations in SMA treatment

4 min read
While Zolgensma has been a life-altering gene therapy for infants with Spinal Muscular Atrophy (SMA), experts widely agree that **Why is Zolgensma not a cure?** is a critical question for managing patient expectations. The single-dose treatment halts disease progression but cannot reverse pre-existing neurological damage, a key distinction from a complete cure.